体重管理补充剂的全球市场-2022-2029
市场调查报告书
商品编码
1146424

体重管理补充剂的全球市场-2022-2029

Global Weight Management Supplements Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期间(2022-2029 年),体重管理补充剂的市场规模预计将以 12.4% 的复合年增长率增长。

旨在添加或补充饮食的维生素、矿物质、草药产品或其他製剂与用于增加或减轻体重的传统食物不同,都被认为是体重控制补充剂。是已知的。

市场动态

越来越多的肥胖患者和对生活方式相关疾病的认识不断提高,推动了对体重管理补充剂的需求。补品具有不吃不喝、不运动也能保持体力、提高免疫力、增肌的作用。

不断上升的肥胖病例和对生活方式疾病的认识不断提高正在推动全球市场的增长。

全球肥胖和超重病例数量的增加以及对生活方式相关疾病的认识不断提高,正在推动全球体重管理补充剂市场的增长。例如,在世界肥胖日,世界卫生组织表示,全球有超过 10 亿人肥胖,其中成年人约 6.5 亿,青少年约 3.4 亿,儿童约 3900 万。肥胖继续增加。世卫组织预测,到 2025 年,将有超过 1.67 亿成人和儿童因肥胖或超重而变得不健康。此外,肥胖会增加患心血管疾病、脂肪肝和糖尿病等非传染性疾病和代谢疾病的风险。因此,非传染性疾病导致的死亡发病率不断上升,正在提高公众对肥胖对健康影响的认识,这反过来又推动了全球体重管理补充剂的整体增长。

缺乏对某些成分的补充剂功效和副作用的保证正在阻碍全球体重管理补充剂市场的增长。

然而,缺乏对补充剂功效和某些成分副作用的保证阻碍了全球体重管理补充剂市场的增长。例如,美国政府问责局的声明得出的结论是,人们对减肥补充剂是否有影响知之甚少,而一些补充剂与潜在的身体伤害有关。我在这里。例如,钙是减肥补充剂中的常见成分,但几项大型临床试验显示对减肥没有明显效果。儘管如此,在这些试验中报告了严重的副作用。

COVID-19 的影响

COVID-19 的爆发对全球体重管理补充剂市场产生了积极影响,因为研究表明肥胖是 COVID-19 住院和死亡的新威胁。例如,世界卫生组织指出 60% 的欧洲人口超重或肥胖,这表明肥胖流行病,尤其是 COVID-19 的影响,因为它造成了增加发病率和死亡率的双重流行病。随着世界人口对体重管理的关注,人们正在选择体重管理补充剂,因为在当今忙碌的生活中很难保持适当的饮食和锻炼 2022 年报告发布了该书。

细分分析

在预测期内(2022-2029 年),预计女性将在体重管理补充剂市场中占据更大份额。

由于性别是肥胖的重要风险因素,预计女性最终用户将在预测期间(2022-2029 年)占据大部分市场份额。女性肥胖的可能性是肥胖男性的两倍,因此与肥胖男性相比,女性患多种与肥胖相关的慢性身体和心理疾病的风险更高,死亡风险是肥胖男性的两倍。已经提出了几个风险因素来解释肥胖表型与性别之间的关係。这些差异对个人的医疗、社会心理和经济影响具有深远的影响。

例如,世界肥胖联盟发布的《2022 年全球肥胖图谱》预测,到 2030 年,将有 10 亿人肥胖,其中包括五分之一的女性和七分之一的男性。这代表着超重女性人口的快速增长,从而主导体重管理补充剂市场。

区域分析

预计北美将主导体重管理补充剂的全球市场。

北美主导着全球体重管理补充剂市场。预计在预测期内(2022-2029 年)将占主导地位,因为通过各种市场策略在体重管理补充剂市场占有很大份额的大多数主要市场参与者都位于美国。例如,康宝莱营养、雅培营养、阿特金斯营养、Nutrisystem、安利等。此外,该地区不断增长的肥胖人口保证了体重管理市场的主导地位。例如,根据全球肥胖观察站的数据,36.47% 的成年男性和 38.16% 的成年女性超重。由于快餐消费占美国人平均饮食的 11% 左右,美国人的肥胖率正在上升。肥胖症每年的成本估计为 1490 亿美元,其中大约一半由医疗保险和医疗补助计划承保。因此,从上述数据推断,在预测期内,北美将主导全球体重管理补充剂市场。

竞争格局

Abbott Laboratories 是一家美国医疗器械和医疗保健公司,成立于 1888 年,总部位于美国伊利诺伊州的 Abbott Park。 Abbott Laboratories 生产和交易医疗器械、诊断产品、品牌仿製药和营养产品。 Abbott Laboratories 拥有 ZonePerfect、PediaSure、Similac、Pedialyte、Juven 和 Nepro 等营养产品品牌。

产品组合

Abbott Laboratories 的体重管理补充剂产品组合包括 ENSURE。确保品牌产品为活跃的成年人提供营养来源,帮助他们专注于特定的营养目标。

全球体重管理补充报告将提供对 40 多个 市场数据表、45 多个数字和 200 页(大约)的访问。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 肥胖病例不断增加
      • 提高认识
    • 限制因素
      • 缺乏有效性保证
      • 副作用
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按形状

  • 软凝胶
  • 药片
  • 粉末
  • 液体

第 8 章最终用户

  • 成年男性
  • 成年女性
  • 老年人
  • 儿童

第 9 章分销渠道

  • 药店
  • 保健美容店
  • 大卖场/超市
  • 在线销售
  • 其他销售渠道

第 10 章按成分分类

  • 维生素和矿物质
  • 氨基酸
  • 植物补充剂
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 13 章公司简介

  • 雅培营养
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Glanbia Nutritionals PLC
  • Herbalife
  • Lovate Health Sciences
  • Oriflame
  • Atkins Nutritional
  • Nestle SA
  • Nutrisystem
  • Bioalpha Holdings Berhad
  • Amway
  • White Heron Pharmaceutical

第14章 DataM

简介目录
Product Code: DMPH252

Market Overview

Weight Management Supplements Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 12.4% during the forecast period (2022-2029).

Any vitamin, mineral, herbal product, or other formulation intended to add to or supplement the diet and is different from conventional food ingested to gain or lose weight is known as a weight management supplement.

Market Dynamics

Growth in obesity cases and increasing awareness of lifestyle diseases drive the demand for weight management supplements. They help maintain fitness without needing a dietary meal or exercise, improve their immune system and build muscle mass.

The growing obesity cases and increasing awareness of lifestyle diseases drive global market growth.

The growing cases of obesity and overweight globally and the increasing awareness about lifestyle diseases are boosting the global weight management supplement market growth. For instance, on world obesity day, WHO presented data that indicated over 1 billion people worldwide are obese, of which around 650 million are adults, nearly 340 million are adolescents, and approximately 39 million are children. The cases of obesity are still increasing. The WHO predicts that over 167 million adults and children will become unhealthy due to obesity or overweight by 2025. Furthermore, with obesity, there is a high risk for non-communicable diseases and metabolic diseases such as cardiovascular diseases, fatty liver diseases, diabetes, Etc. Thus, the increasing incidences of non-communicable diseases caused deaths is increasing awareness in the population about the impacts of obesity on health which in turn is fueling the overall growth of the global weight management supplement.

The lack of assurance about the effectiveness of the supplements and the side effects of a few ingredients is hampering the global weight management supplement market growth.

However, the lack of assurance about the effectiveness of the supplements and the side effects of a few ingredients is hampering the global weight management supplement market growth. For instance, the declaration from the U.S. Government Accountability Office concluded that remarkably little is apprehended about whether weight loss supplements are influential, while some supplements have been associated with the potential for physical harm; for example, Calcium is one of the common ingredients from weight management supplement which has not shown any evident effect on weight loss in several large clinical trials. Still, there have been reports of severe adverse effects in these trials.

COVID-19 Impact.

The COVID-19 outburst has positively impacted the global weight management supplement market, as studies indicated that obesity is a novel threat to hospitalization and death due to COVID-19. For instance, WHO released a 2022 report on the state of the obesity pandemic in Europe, showing that 60% of the population in Europe is either overweight or obese and insinuating the effects of the obesity pandemic, particularly as it interacts with the COVID pandemic to creating a twin pandemic boosting the morbidity and mortality, which has increased the world population focus towards weight management, and since maintaining proper diet and exercise in today's busy life is difficult people are opting for weight management supplements.

Segment Analysis

Female are expected to have a greater grasp of the weight management supplements market during the forecast period (2022-2029).

Female end users are expected to hold most of the market share throughout the forecast period (2022-2029) as gender is an important risk factor for the development of obesity. The female gender is at twice the danger of being obese; thereby are at higher risk of acquiring multiple chronic obesity-related physical and psychological conditions and have a double mortality risk compared to obese men. Some risk factors have been represented to describe the gender relation with an obese phenotype. These disparities have far-reaching implications on an individual's medical, psychosocial, and economic impact.

For instance, the World Obesity Atlas 2022, issued by the World Obesity Federation, anticipates that one billion people globally, including 1 out of 5 women and 1 out of 7 men, will be obese by 2030, indicating that the overweight female population is increasing rapidly, thus, dominating the weight management supplement market.

Geographical Analysis

North America is expected to dominate the global weight management supplements market.

North America commands the global weight management supplement market. It is anticipated to dominate during the forecast period (2022-2029) as most of the key market players holding a large share of the weight management supplement market through various market strategies are U.S. based. For instance, Herbalife Nutrition, Abbott Nutrition, Atkins Nutritional, Nutrisystem and Amway. Furthermore, the growing obese population in this region ensures its dominance over the weight management market. For instance, as per the Global Obesity Observatory, 36.47% of adult males and 38.16% of adult females are overweight. The increasing obesity in the American population is due to fast-food consumption, which makes up about 11% of the average American diet. Obesity is estimated to increase healthcare spending by $149 billion annually, about half of which is paid for by Medicare and Medicaid. Therefore, with the above-mentioned data, it is estimated that North America will dominate the global weight management supplement market during the forecast period.

Competitive Landscape

The key players operating in the global weight management supplements market are Abbott Nutrition, Glanbia Nutritionals PLC, Herbalife, Lovato Health Sciences, Oriflame, Atkins Nutritional, Nestle SA, Nutrisystem, Bioalpha Holdings Berhad, Amway, and White Heron Pharmaceutical. The key players are embracing various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the weight management supplements market globally. For instance, in July 2022, Herbalife Nutrition launched Fat Release to support its consumers' healthy and active lifestyles. This product enables trimming the fat from food to uphold consumers on track with their health objectives.

Abbott Laboratories.

Overview:

Abbott Laboratories is an American global medical device and healthcare company founded in 1888 with headquarters in Abbott Park, Illinois, United States. Abbott Laboratories manufacture and trades medical devices, diagnostics, branded generic medicines and nutritional products. Abbott Laboratories has nutrition product brands such as ZonePerfect, PediaSure, Similac, Pedialyte, Juven, Nepro, Etc.

Product Portfolio:

The product portfolio of Abbott Laboratories for weight management supplements has ENSURE: The Ensure brand products nourish active adults with a source of nutrition that can aid them in focusing on explicit nutritional goals.

The global weight management supplements report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Cases of Obesity
      • 4.1.1.2. Increasing Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Effectiveness Assurance
      • 4.1.2.2. Side Effects
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Soft Gel
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Pills
  • 7.4. Powder
  • 7.5. Liquid

8. By End Users

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 8.1.2. Market Attractiveness Index, By End Users
  • 8.2. Adult Men
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Adult Women
  • 8.4. Senior Citizens
  • 8.5. Children

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Drug Store
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Health & Beauty Store
  • 9.4. Hypermarket/Supermarket
  • 9.5. Online Sales
  • 9.6. Other Sales Channel

10. By Ingredients

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredients
    • 10.1.2. Market Attractiveness Index, By Ingredients
  • 10.2. Vitamins & Minerals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Amino Acids
  • 10.4. Botanical Supplements
  • 10.5. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Ingredient

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Abbott Nutrition
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Glanbia Nutritionals PLC
  • 13.3. Herbalife
  • 13.4. Lovate Health Sciences
  • 13.5. Oriflame
  • 13.6. Atkins Nutritional
  • 13.7. Nestle SA
  • 13.8. Nutrisystem
  • 13.9. Bioalpha Holdings Berhad
  • 13.10. Amway
  • 13.11. White Heron Pharmaceutical

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us